Statement on the childhood flu programme: the alternative offer to live attenuated Influenza vaccine (LAIV)

This statement confirms that as of 18 November, inactivated Influenza vaccine (IIV) is being made available to children whose parents refuse live attenuated Influenza vaccine (LAIV) due to the porcine gelatine content, subject to vaccine availability.

SPS commentary:

Public Health England has issued a statement confirming that the ‘Inactivated Influenza Vaccine patient group direction (PGD) V08.00’ may be extended to this group of children.

Source:

Public Health England

Resource links:

Inactivated influenza vaccine PGD – extension of eligible cohorts